|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9100
|
|
pubmed:dateCreated |
1998-3-18
|
|
pubmed:abstractText |
We assessed the effectiveness of a 23-valent pneumococcal vaccine in the prevention of pneumococcal pneumonia and of pneumonia overall in non-immunocompromised middle-aged and elderly people.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
7
|
|
pubmed:volume |
351
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
399-403
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9482293-Aged,
pubmed-meshheading:9482293-Aged, 80 and over,
pubmed-meshheading:9482293-Bacterial Vaccines,
pubmed-meshheading:9482293-Double-Blind Method,
pubmed-meshheading:9482293-Female,
pubmed-meshheading:9482293-Follow-Up Studies,
pubmed-meshheading:9482293-Humans,
pubmed-meshheading:9482293-Incidence,
pubmed-meshheading:9482293-Male,
pubmed-meshheading:9482293-Middle Aged,
pubmed-meshheading:9482293-Pneumococcal Vaccines,
pubmed-meshheading:9482293-Pneumonia,
pubmed-meshheading:9482293-Pneumonia, Pneumococcal,
pubmed-meshheading:9482293-Proportional Hazards Models,
pubmed-meshheading:9482293-Prospective Studies,
pubmed-meshheading:9482293-Recurrence,
pubmed-meshheading:9482293-Risk Factors,
pubmed-meshheading:9482293-Streptococcus pneumoniae,
pubmed-meshheading:9482293-Vaccination
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group.
|
|
pubmed:affiliation |
Division of Infectious Diseases, Karolinska Institutet, Danderyd Hospital, Sweden. ake.ortqvist@inf.ds.sll.se
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
